Please login to the form below

Not currently logged in
Email:
Password:

Bayer's Martin Hesse moves to Daiichi Sankyo Europe

Will succeed Max Schöner, who retires in December after 12-years as CFO

Daiichi Sankyo CFO Martin HesseDaiichi Sankyo has appointed Martin Hesse to be its new European chief financial officer (CFO) with effect from October, 1.

He will succeed Max Schöner, who retires on December, 31 after 12-years in the role, and joins Daiichi Sankyo Europe from Bayer, where he had served since 1984.

Hesse was most recently chief administration officer excellence at Bayer Healthcare, having previously held a series of senior roles that included VP of corporate auditing and CFO for Eastern Europe.

Daiichi Sankyo Europe's CEO Reinhard Bauer said: “We are excited that we could fill the position with such an expert.

“Daiichi Sankyo Europe is playing an increasingly important role within the group. It will be a major contributor in our effort to generate the bigger part of our group sales outside Japan. In his former positions, Hesse has proven his ability to achieve ambitious goals like these.” 

Commenting on the environment in which he starts at Daiichi, Hesse said securing the company's profitability and competitiveness in the light of drug pricing interventions will a major challenge.

“We'll have to come to terms with every mandatory discount. The key will be to skilfully combine cost reductions with strategic decisions.”

11th September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics